SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Dog (Bitcoin) is a fully decentralized memecoin on the Bitcoin blockchain, backed by a community dedicated to onboarding millions of people to Bitcoin.  Dog is secured by the Bitcoin blockchain and exists on Bitcoin L1, marking a significant innovation compared to Bitcoin with just BTC. Dog is a Bitcoin Runes token with a minimal on-chain footprint, native to Bitcoin, and stored in UTXOs, just like Bitcoin.   What is the project about?  Dog does not do any paid promotion and is fully decentralized just like Bitcoin. Every influencer who chooses to post about Dog either received the airdrop or bought on secondary. Dog leverages the CC0 license to ensure that Dog is not owned by any single entity but rather by everyone. This had lead to the "DOG Army" independently creating art, apps, lotteries, plushies, websites, podcast, magazines, X account, IRL meetups, clothing lines, PFP collections, Telegram groups, and TikTok/Instagram about Dog.  What makes your project unique?  Dog was airdropped in the fairest memecoin launch ever. In early 2024, the Bitcoin Ordinals ecosystem came together in a full volunteer initiative that rewarded early adopters of the Ordinals Protocol. There was no team allocation, and 100% of the supply was airdropped for free. The airdrop algorithm favored neither whales nor influencers; it was determined by the community and made open-source for maximum transparency.

Dog (Bitcoin)

$DOG.X is trending as a Bitcoin-native meme coin launched via the Runes protocol, inheriting Bitcoin's decentralized ethos and aiming to onboard retail investors to the Bitcoin ecosystem. The community emphasizes its fair launch and potential to surpass other meme coins like DOGE by leveraging Bitcoin's network security; discussions also highlight the backing from $CBLO.

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

Summit Therapeutics is trending amid community chatter about a potential licensing deal and speculation around upcoming data releases. Discussions revolve around the company's strategic direction and the potential impact of ongoing clinical trials for their lung cancer drug. Bullish investors are highlighting insider buying and the drug's potential to compete with existing treatments.

Gyrodyne LLC engages in the management of a portfolio of medical office and industrial properties. Its properties include Flowerfield, Port Jefferson Professional Park, Courtland Medical Center, and Grove. The company was founded by Peter James Papadakos in 1946 and is headquartered in St. James, NY.

Gyrodyne LLC

GYRO is trending due to news of a land sale boosting its NAV, with the community focusing on its low float and potential for a significant upward move. Chatter suggests the stock is undervalued, with some anticipating a potential squeeze and rapid price increase if key resistance levels are broken. Investors are closely watching for a breakout and considering potential entry points.

BrokeCoin is a meme-meets-utility cryptocurrency project operating under the ethos of Transparency, Community, and Respect. Formally registered as an LLC in Wyoming, USA, BrokeCoin is building an expansive ecosystem that combines light-hearted spirit of meme culture with real-world crypto utilities—spanning gaming, staking, NFTs, web services, and an e-commerce platform. Brokecoin believes in developing useful and interesting meme-inspired utilities to both service the crypto industry, and generate value for holders.

Brokecoin

$BROKE.X is trending as the community rallies around its active development team, which is focused on building utility and staking options. Community members are excited about upcoming burns and contests, and many believe the coin is undervalued. The conversation highlights the coin's strong community and dedication to breaking into the top trending spot.

ProShares Trust - ProShares Short Dow30 -1x Shares

ProShares Short Dow30

ProShares Short Dow30 ($DOG) is trending as the crypto community rallies behind Dog of Bitcoin ($DOG), viewing it as more than just a memecoin but as a movement rooted in Bitcoin's principles. Supporters believe $DOG embodies a fair, decentralized, and community-driven approach, positioning it as a potential successor to Dogecoin and a significant player in the Bitcoin Layer-2 ecosystem.

Infinite Money Glitch ($IMG) is revolutionizing DeFi on Solana by leveraging the Token2022 program's advanced tax extension capabilities to create a truly innovative reward system for token holders.  At its core, $IMG implements a seamless 5% tax on all transactions - whether buying, selling, or transferring tokens. This tax is automatically collected and distributed to holders in SOL, creating a sustainable passive income stream for the community. 4.5% of the tax gets sent to holders, while .5% gets sent to an Infrastructure wallet to help with development, marketing and general infrastructure.  What sets $IMG apart is its implementation of Solana's Token2022 program, enabling automated and efficient reward distribution without relying on external smart contracts.

Infinite Money Glitch

Infinite Money Glitch ($IMG.X) is trending as community members highlight its unique protocol that rewards holders with $SOL.X based on trading volume, promoting it as a DeFi savings account. The community is rallying behind the token's resilience and potential for long-term growth, emphasizing its community-led nature and new partnerships. Discussions also highlight the shift towards web 4.0 protocols rewarding user belief rather than hype, positioning $IMG.X as a leading example on the Solana blockchain.

Rapport Therapeutics, Inc. engages in the discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. It develops the RAP (receptor associated proteins) technology platform. The company was founded by Steven M. Paul and David Bredt in February 2022 and is headquartered in Boston, MA.

Rapport Therapeutics Inc.

Rapport Therapeutics Inc

Rapport Therapeutics ($RAPP) is trending due to anticipation surrounding the upcoming topline results for its RAP-219 Phase 2a trial in focal onset seizures. The community is discussing whether the news will be positive and lead to further gains, or if it will be a "sell the news" event after the recent after-hours surge. Some traders are also noting the stock's low float and potential for volatility.

Vulcan Materials Co. engages in the production of construction aggregates. It operates through the following segments: Aggregates, Asphalt, and Concrete. The Aggregates segment produces and sells aggregates and related products and services. The Asphalt segment relates to the production and selling of asphalt mix in Arizona, California, New Mexico, Tennessee, and Texas. The Concrete segment refers to the production and selling of ready-mixed concrete in California, Maryland, and Virginia in addition to the U.S. Virgin Islands and Washington D.C. The company was founded in 1909 and is headquartered in Birmingham, AL.

Vulcan Materials Co

Vulcan Materials is trending as investors monitor the building materials sector, particularly in light of anticipated infrastructure spending and construction demand. Community members are discussing valuation and growth prospects, with some highlighting Vulcan's potential for continued earnings expansion. Recent analyst target adjustments and upcoming investor day events are also driving interest in the stock.

B3 is a Layer 3 blockchain settlement layer built on Base, designed to revolutionize onchain gaming through its [Open Gaming](https://opengaming.b3.fun/) ecosystem. By addressing key pain points in blockchain-based gaming, B3 enhances accessibility for both developers and players. Its infrastructure minimizes transaction costs, simplifies onboarding, and fosters a collaborative ecosystem where games share liquidity, incentives, and audiences.  The $B3 token serves as the backbone of the ecosystem, ensuring seamless interaction across multiple games and chains, enabling  * Governance * Staking * In-game transactions

B3DOTFUN

B3.X is trending as the community discusses its potential within the gaming sector and recent price action, with some speculating on upcoming announcements or partnerships as catalysts. Community members are debating whether it's a promising opportunity or a potential "scam," pointing to low volume and concerns about project execution. Despite mixed sentiment, there is excitement around staking rewards and potential for a significant run, particularly with the anticipation of alt season.

IDEAYA Biosciences, Inc. engages in the research and development of oncology-focused precision medicine. It focuses on the targeted therapeutics for patients selected using molecular diagnostics. Its product candidate, IDE196, is a protein kinase C inhibitor for genetically defined cancers having GNAQ or GNA11 gene mutations. The company was founded by Yujiro S. Hata and Jeffrey Hager in June 2015 and is headquartered in South San Francisco, CA.

Ideaya Biosciences Inc

IDYA is trending due to positive Phase 2 data and a successful FDA meeting regarding its uveal melanoma treatment, darovasertib, potentially leading to accelerated approval. Community members are focused on the drug's efficacy and potential for eye preservation, as well as upcoming presentations. Analysts are also weighing in with positive ratings and price target adjustments, citing a promising pipeline beyond its lead asset.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

BYD has reportedly cut its 2025 sales target by as much as 16% to 4.6 million vehicles, marking what could be its slowest annual growth in five years and a sign its record-breaking expansion may be ending.&nbsp;China’s largest automaker had told analysts in March it was aiming for 5.5 million sales, but the target has been reduced several times since, with the latest figure shared internally and with select suppliers last month, Reuters&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="https://www.reuters.com/business/autos-transportation/chinas-byd-cuts-2025-sales-target-by-16-sources-say-a-sign-its-white-hot-growth-2025-09-04/">reported</a>, citing people familiar with the matter.The goal remains subject to change depending on market conditions. The downgrade comes as BYD faces intensifying competition from rivals such as Geely Auto and Leapmotor,&nbsp;according to the report.BYD last week posted a 30% plunge in quarterly profit, marking its first drop in more than three years. Wall Street is also trimming expectations, with Deutsche Bank forecasting sales of 4.7 million vehicles this year and Morningstar putting the figure at 4.8 million.&nbsp;Analysts at Deutsche Bank and Morningstar now expect BYD to sell 4.7 million and 4.8 million vehicles, respectively, this year. The revised target represents 7% growth from last year but would be the weakest pace since 2020, when sales fell 7%.In the first eight months of 2025, BYD achieved only 52% of its original target. The slowdown highlights the broader deflationary pressures on China’s economy amid a prolonged housing downturn.&nbsp;Though BYD’s sales of EVs and plug-in hybrids surged tenfold between 2020 and 2024 to 4.3 million units, putting it on par with General Motors and Ford, growth is cooling in its main market of China, where it derives nearly 80% of sales and faces a bruising price war.BYD has slowed production, delayed factory expansion, and seen sales of economy cars under 150,000 yuan, its core domestic segment, fall 9.6% year-on-year in July.&nbsp;In contrast, Geely’s sales in the same category jumped 90%, and the company raised its 2025 sales target to 3 million vehicles from 2.71 million. BYD’s production also fell for a second consecutive month in August, the first back-to-back contraction since 2020.On Stocktwits, retail sentiment for BYD was ‘bullish’ amid ‘high’ message volume.<a href="https://stocktwits.com/symbol/BYDDF">BYD’s U.S.-listed stock</a> has risen 23.8% so far in 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.

BYD electric cars carmaker logo is seen at the BYD saloon in Warsaw, Poland on March 22, 2025. (Photo by NurPhoto via Getty Images)

Is BYD's Boom Fading? China's EV Leader Said To Slash 2025 Sales Target By Nearly A Million Units

The company last week reported its first quarterly profit drop in over three years, while rivals like Geely are gaining ground and even raising their own sales targets.

Equity

Sales of electric vehicles from Tesla Inc. (TSLA), General Motors Co. (GM), Ford Motor Co. (F), and other players in the U.S. could be cut in half as President Donald Trump’s “One Big Beautiful Bill Act” ends federal EV credits later in September, according to an automobile industry expert.According to a&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="https://finance.yahoo.com/news/ev-armageddon-tesla-gm-ford-ev-sales-will-be-cut-in-half-when-tax-credit-expires-analyst-says-124602947.html">report</a> by Yahoo Finance citing inputs from iSeeCars.com analyst Karl Brauer, although EV sales could rise in the third quarter (Q3) due to a potential rush from buyers ahead of the September 30 deadline for claiming EV tax credits, they would see a steep fall off once the deadline kicks in.<a href="https://stocktwits.com/symbol/TSLA">Tesla’s shares</a> gained 4% in Wednesday’s opening trade, while&nbsp;<a href="https://stocktwits.com/symbol/GM">GM’s shares</a> edged up by 0.03% and&nbsp;<a href="https://stocktwits.com/symbol/F">Ford’s shares</a> were down 0.55% at the time of writing. Retail sentiment on Stocktwits around Tesla and Ford trended in the ‘bearish’ territory, while users felt ‘neutral’ about GM.“I think then ... we're going to see a pretty big drop. I could see US [market share] dropping well below 4% immediately after the September 30 incentive goes away and maybe settling in the beginning of 2026, around 4%,” Brauer added. According to&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="https://www.coxautoinc.com/market-insights/ev-market-monitor-july-2025/">data</a> from Cox Automotive, EVs held a 9.1% market share in the U.S. in July, rising from 8% in June and 6.9% in May.Brauer added that companies could try to keep the sales momentum going by offering discounts on their EVs once the federal tax incentives expire at the end of September.This comes at a time when EV giant Tesla is&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/tesla-sales-fall-germany-european-markets-continue-to-decline/chwTUgeRd8Z">struggling in Europe</a>, with sales plummeting across several countries in the region in August.<a href="https://stocktwits.com/symbol/TSLA">TSLA stock</a> is down 18% year-to-date, whereas&nbsp;<a href="https://stocktwits.com/symbol/GM">GM stock</a> is up 10% and&nbsp;<a href="https://stocktwits.com/symbol/F">F stock</a> is up 18%.Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/tesla-sales-fall-germany-european-markets-continue-to-decline/chwTUgeRd8Z">Tesla Sales Continue To Tumble In Germany As Its Struggles In Europe Continue: Report</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

New Tesla electric vehicles fill the car lot at the Tesla retail location on Route 347 in Smithtown, New York on July 5, 2023. (Photo by John Paraskevas/Newsday RM via Getty Images)

Tesla, GM, Other EV Sales To Tumble By 50% As Trump Ends Federal EV Credits Later This Month, Says Expert: Report

According to auto analyst Karl Brauer, EV sales could rise in the third quarter due to a potential rush to claim federal tax credits, but there could be a steep decline after the deadline kicks in.

General Motors Company (GM) Is a Trending Stock: Facts to Know Before Betting on It

Zacks.com users have recently been watching General Motors (GM) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Why Is Ford Motor (F) Up 5.8% Since Last Earnings Report?

Ford Motor (F) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Can Ford's BlueOval Charge Network Make EV Road Trips Easier?

F expands its BlueOval Charge Network, opening 1,200 dealership fast chargers to all EV drivers across North America.

Does GM's Factory Zero Shift Cut Signal a Slowdown in its EV Push?

General Motors is cutting shifts for its Hummer EV and Escalade IQ at Factory Zero, underscoring weaker U.S. demand.

Can QuantumScape's Business Model Reduce Losses & Boost Stability?

QS' dual revenue model of development fees and royalties aims to cut losses and build financial stability.

Ford's Recall Headache: Could This Stall Its Profitability Drive?

F recalls 355,000 trucks over instrument panel faults, stepping up testing to restore quality and rebuild customer trust.

Auto Giants Face-Off: GM vs. STLA - Which Stock Wins Out?

GM leverages U.S. strength and rising EV demand, while Stellantis struggles with weak sales, losses and leadership change.

U.S. auto safety regulator stated on Tuesday that automaker General Motors (GM) is recalling 23,656 Chevrolet Corvette vehicles in the country over heightened risks of fire.The recall involves model year 2023-2026 Corvette vehicles equipped with a left-side radiator or fan combination, including some Corvette convertibles and coupes. Excess fuel may spill into the vehicle fuel-filler pocket during refueling and leak onto an ignition source such as a hot engine or exhaust components, increasing the risk of a fire, the National Highway Traffic Safety Administration (NHTSA) <a target="_blank" rel="noopener noreferrer nofollow" href="https://static.nhtsa.gov/odi/rcl/2025/RCLRPT-25V536-9882.pdf">said</a>.The regulator said that dealers will install a shield to divert spilled fuel, at no cost to the customer, to resolve the issue. On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/GM">GM stock</a> fell from ‘neutral’ to ‘bearish’ territory over the past 24 hours, while message volume remained at ‘low’ levels.<figure class="image"><img style="aspect-ratio:576/63;" src="https://news.stocktwits-cdn.com/Screenshot_2025_08_26_at_9_04_07_AM_png_997caba829.webp" alt="GM's Sentiment Meter and Message Volume as of 9:04 a.m. ET on Aug. 26, 2025 | Source: Stocktwits" width="576" height="63"><figcaption>GM's Sentiment Meter and Message Volume as of 9:04 a.m. ET on Aug. 26, 2025 | Source: Stocktwits</figcaption></figure>A Stocktwits user noted earlier that the stock will rally soon.<stembedurl>https://stocktwits.com/Derrick20042008/message/626503875</stembedurl>The recall follows an employee submitting a report to the company after reading a social media post alleging that three Corvette vehicles experienced a fire while fueling during a 30-day period. On June 12, a fourth incident occurred in a GM-owned development Corvette test vehicle. GM subsequently opened a product investigation on June 17.GM’s investigation identified four alleged fires that are potentially relevant to the condition. Customer reports, photographs, and video evidence indicated that malfunctioning filling station pumps were a contributing factor in at least two of the four field fires, GM said. It added that two of these incidents involved minor alleged injuries. The company then decided to conduct a safety recall.GM also said in the recall report that owners should always confirm that the fuel nozzle is completely inserted into the vehicle’s fuel pipe before fueling to reduce the risk of fire and turn off the vehicle’s engine during refuelling.GM stock is up by 13% this year and by about 19% over the past 12 months.&nbsp;Also See: <a href="https://stocktwits.com/news-articles/markets/equity/why-is-incannex-healthcare-surging-today/chsHHZBRdjh">Why Is Incannex Healthcare Stock Surging Today?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com

A new 2025 Chevrolet Corvette on display at the Edmonton Motor Show on April 13, 2025, in Edmonton, Alberta, Canada. (Photo by Artur Widak/NurPhoto via Getty Images)

GM Recalls Nearly 24,000 Chevrolet Corvette Vehicles In The US: Find Out Why

The recall involves model year 2023-2026 Corvette vehicles equipped with a left-side radiator or fan combination, including some Corvette convertibles and coupes.

General Motors Co. engages in the designing, manufacturing, and selling of trucks, crossovers, cars, and automobile parts, and in providing software-enabled services and subscriptions. It operates through the following segments: GMNA, GMI, Cruise, and GM Financial. The company was founded by William C. Durant on September 16, 1908 and is headquartered in Detroit, MI.

GM
General Motors Company

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest GM News

GM General Motors Company